Nutex Health (NASDAQ:NUTX) Downgraded by Zacks Research to "Hold"

Key Points

• Zacks Research downgraded Nutex Health from “strong buy” to “hold,” though other analysts remain positive. The stock has an overall “Moderate Buy” consensus rating with a $317.50 average price target.
• Nutex Health reported quarterly EPS of $9.38, surpassing the $4.95 consensus estimate, while revenue of $210.75 million came in slightly below expectations.
• Shares opened at $213.02 and remain near their 12-month high of $226.16. An insider also sold 203 shares, while institutional investors recently increased or initiated positions in the company.

Nutex Health (NASDAQ:NUTX - Get Free Report) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating in a note issued to investors on Tuesday, Zacks reports.

Other equities research analysts have also issued reports about the company. Weiss Ratings raised Nutex Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Tuesday. Wall Street Zen raised shares of Nutex Health from a "hold" rating to a "buy" rating in a report on Saturday, October 3rd. Lake Street Capital restated a "buy" rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Finally, B. Riley Financial restated a "buy" rating on shares of Nutex Health in a report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $317.50.

Nutex Health Price Performance

Shares of NASDAQ NUTX opened at $213.02 on Tuesday. The company has a market capitalization of $1.46 billion, a PE ratio of 8.36 and a beta of 0.55. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. The stock's 50 day moving average price is $193.00 and its 200-day moving average price is $154.54. Nutex Health has a twelve month low of $83.99 and a twelve month high of $226.16.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The company had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. On average, equities analysts anticipate that Nutex Health will post 27.58 EPS for the current year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business's stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director owned 400 shares of the company's stock, valued at $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 44.68% of the stock is owned by insiders.

Hedge Funds Weigh In On Nutex Health

Large investors have recently made changes to their positions in the stock. Corient Private Wealth LP purchased a new stake in shares of Nutex Health in the second quarter worth about $1,142,000. Quantinno Capital Management LP purchased a new position in Nutex Health during the first quarter valued at approximately $843,000. Empowered Funds LLC bought a new stake in Nutex Health during the 2nd quarter worth approximately $7,720,000. First Trust Advisors LP increased its holdings in Nutex Health by 60.0% during the 1st quarter. First Trust Advisors LP now owns 18,335 shares of the company's stock worth $1,743,000 after acquiring an additional 6,874 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in Nutex Health in the 2nd quarter worth approximately $3,956,000. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.